Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... 2009, and was entitled, "Progesterone Vaginal Gel as Effective, Better Tolerated Than Hormone Injections During IVF". The study was supported in part by a grant from Columbia ... 8% was the first FDA-approved natural progesterone for progesterone supplementation or replacement as part of Assisted Reproductive Technology (ART) treatments for infertile women with ... in collaboration with the NIH, the PREGNANT (PROCHIEVE® Extending GestatioN A New Therapy) Study, a randomized, double blind, placebo controlled 450-patient Phase III clinical ...
2009 NOV 16 ... ethical treatment of growth hormone deficiency in affected patients. Growth hormone replacement therapy has proven useful for children and adults with scientifically proven growth hormone ...
2009 NOV 2 ... (Nasdaq: CBRX). About Progesterone and Luteal Phase Support Progesterone is a hormone naturally found in a woman's body, which creates a healthy environment in the uterus, ... 8% was the first FDA-approved natural progesterone for progesterone supplementation or replacement as part of Assisted Reproductive Technology (ART) treatments for infertile women with ... Menstruation, Obstetrics, Pharmaceuticals, Pregnancy, Progesterone, Reproductive Health, Therapy, Treatment, Women's Health, Columbia Laboratories Inc. This article was ...
2009 NOV 2 ... Inc. (Nasdaq: CBRX) About Progesterone and Luteal Phase Support Progesterone is a hormone naturally found in a woman's body, which creates a healthy environment in the uterus, ... 8% was the first FDA-approved natural progesterone for progesterone supplementation or replacement as part of Assisted Reproductive Technology (ART) treatments for infertile women with ... Pharmaceuticals, Pregnancy, Progesterone, Reproductive Health, Reproductive Medicine, Therapy, Treatment, Women's Health, Columbia Laboratories Inc. This article was ...
2009 NOV 2 ... pathway to parenthood." About Progesterone and Luteal Phase Support Progesterone is a hormone naturally found in a woman's body, which creates a healthy environment in the uterus, ... 8% was the first FDA-approved natural progesterone for progesterone supplementation or replacement as part of Assisted Reproductive Technology (ART) treatments for infertile women with ... Obstetrics, Pharmaceuticals, Pregnancy, Progesterone, Reproductive Health, Surgery, Therapy, Treatment, Women's Health, Columbia Laboratories Inc. This article was ...
2009 NOV 2 ... Inc. (Nasdaq: CBRX) About Progesterone and Luteal Phase Support Progesterone is a hormone naturally found in a woman's body, which creates a healthy environment in the uterus, ... 8% was the first FDA-approved natural progesterone for progesterone supplementation or replacement as part of Assisted Reproductive Technology (ART) treatments for infertile women with ... the most comprehensive comparison of these two routes of administration for progesterone therapy," said Elena H. Yanushpolsky, MD, Director, Reproductive Surgery, Center for ...
2009 NOV 2 ... when the parathyroid glands, through lack of secretion of or resistance to parathyroid hormone (PTH), are unable to maintain calcium homeostasis. Transient and permanent ... and hypercalcemia, have prompted investigation into alternatives, namely PTH replacement and parathyroid gland autotransplantation," wrote V.W. Harris and colleagues, Johns ... the rapidity of action, and ease of reversal of toxicity. Drawbacks to conventional therapy, including narrow therapeutic window and propensity for hypercalciuria and ...
2009 NOV 2 ... details of the patients were noted. Baseline serum thyroxine, thyroid-stimulating hormone (TSH), and prolactin estimation was done in all cases. Thyroid peroxidase antibody ... in patients with benign breast disorders (BBD). We then asked if thyroxine replacement in hypothyroid patients has any impact on the clinical outcome of the BBD," scientists ... conservative management protocol, hypothyroid patients were given thyroxine replacement therapy. Their response to treatment was assessed at 3-month intervals. The clinical outcomes of ...
2009 NOV 2 ... injection) is being evaluated in a Phase 3 registration study known as REPLACE as a hormone replacement therapy for hypoparathyroidism. NPS complements its proprietary programs with a royalty-based ...
2009 NOV 23 ... from a mean of 1.7 +/- 0.1 to 1.5 +/- 0.07 mmol/L and has been adapted to parathyroid hormone serum levels (from 1 to 1.75 mmol/L). The use of calcium-based and aluminum-based ... appropriate strategy, mostly consisting of native vitamin D supplementation, progressive replacement of calcium-based phosphate binders with non-calcium-based ones, and individualization of ... Hyperparathyroidism, Mineral Metabolism, Phosphate Binder, Renal Dialysis, Sevelamer, Therapy, Treatment. This article was prepared by Biotech Business Week editors from ...
2009 NOV 9 ... "Little is known about the effects of various types, modes, and routes of hormone replacement therapy (HRT) on the risk of colorectal cancer (CRC) among postmenopausal women. We conducted a ...
2009 NOV 1 ... estradiol (E2) levels and 9-year mortality in older postmenopausal women not taking hormone replacement therapy (HRT). Population-based study of persons living in the Chianti geographic area (Tuscany, ...
2009 NOV 23 ... men with hypopituitarism (age 53 center dot 1 +/- 4 center dot 1 years) with both growth hormone (GH) and testosterone deficiency were studied sequentially after 2 weeks of treatment ... "Fat mass is increased in hypogonadal men and the changes are reversed by testosterone replacement. Testosterone administration enhances whole body fat oxidation (Fox)," researchers in ... Drugs, Endocrinology, Hormones, Hypopituitarism, IGF I, Pharmaceuticals, Testosterone, Therapy, Transdermal, Treatment, St. Vincent's Hospital. This article was prepared ...
2009 NOV 23 ... and lower numbers of corpora lutea. Sexual receptivity, examined after ovariectomy and hormonereplacement, was normal in all groups except those neonatally exposed to EB. FOS ... Gynecology, Hormones, Lordosis, Neuroendocrinology, Pharmaceuticals, Physiology, Therapy, Treatment, Women's Health, North Carolina State University. This article ...
2009 NOV 9 ... in a trial of neoadjuvant anti-estrogen therapy followed by definitive excision. on hormone replacement therapy, with palpable masses, or with histologic or clinical suspicion of invasion were ...
2009 NOV 9 ... and prevention, as well as to the development of compounds that can be used for hormone replacement therapy in postmenopausal women. He has received several prestigious awards for his research ...
2009 NOV 16 ... self-administration of drug therapies for chronic conditions such as pain management and hormone replacement therapy." A new report that presents a comprehensive assessment of the current ...
